BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan Y, Liang X, Ma Z, Hu H, Liu H, Miao Z, Linkermann A, Hellwege JN, Voight BF, Susztak K. A single genetic locus controls both expression of DPEP1/CHMP1A and kidney disease development via ferroptosis. Nat Commun 2021;12:5078. [PMID: 34426578 DOI: 10.1038/s41467-021-25377-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Mo T, Long P, Wang Y, Peng R, Niu R, Wang Q, Jiang J, Shi L, Yang H, Xu C, Zhang X, He M, Guo H, Wu T. Genetic susceptibility, homocysteine levels, and risk of all-cause and cause-specific mortality: A prospective cohort study. Clin Chim Acta 2023;538:1-8. [PMID: 36347331 DOI: 10.1016/j.cca.2022.11.001] [Reference Citation Analysis]
2 Iwasaki T, Kamatani Y, Sonomura K, Kawaguchi S, Kawaguchi T, Takahashi M, Ohmura K, Sato TA, Matsuda F. Genetic influences on human blood metabolites in the Japanese population. iScience 2023;26:105738. [PMID: 36582826 DOI: 10.1016/j.isci.2022.105738] [Reference Citation Analysis]
3 Lu Y, Wang D, Zhu Y, Du Y, Zhang J, Yang H. A risk model developed based on necroptosis to assess progression for ischemic cardiomyopathy and identify possible therapeutic drugs. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1039857] [Reference Citation Analysis]
4 Xu B, Zhang Y, Chen G, Feng J, Gan L. Association of mean platelet volume/lymphocyte ratio with inflammation in non-dialysis patients with chronic kidney disease stages 1–4: A retrospective study. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1041356] [Reference Citation Analysis]
5 Li S, Wang R, Wang Y, Liu Y, Qiao Y, Li P, Chen J, Pan S, Feng Q, Liu Z, Liu D. Ferroptosis: A new insight for treatment of acute kidney injury. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1065867] [Reference Citation Analysis]
6 Ide S, Ide K, Abe K, Kobayashi Y, Kitai H, McKey J, Strausser SA, O'Brien LL, Tata A, Tata PR, Souma T. Sex differences in resilience to ferroptosis underlie sexual dimorphism in kidney injury and repair. Cell Rep 2022;41:111610. [PMID: 36351395 DOI: 10.1016/j.celrep.2022.111610] [Reference Citation Analysis]
7 Hu W, Chen X. Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics. Sci Rep 2022;12:18826. [PMID: 36335193 DOI: 10.1038/s41598-022-23730-8] [Reference Citation Analysis]
8 Zhou Y, Zhang J, Guan Q, Tao X, Wang J, Li W. The role of ferroptosis in the development of acute and chronic kidney diseases. J Cell Physiol 2022. [PMID: 36260516 DOI: 10.1002/jcp.30901] [Reference Citation Analysis]
9 Shi Z, Zheng J, Liang Q, Liu Y, Yang Y, Wang R, Wang M, Zhang Q, Xuan Z, Sun H, Wang K, Shao C. Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma. Cancers 2022;14:4690. [DOI: 10.3390/cancers14194690] [Reference Citation Analysis]
10 Phadnis VV, Snider J, Wong V, Vaccaro KD, Kunchok T, Allen J, Yao Z, Geng B, Weiskopf K, Stagljar I, Henry WS, Weinberg RA. MMD scaffolds ACSL4 and MBOAT7 to promote polyunsaturated phospholipid synthesis and susceptibility to ferroptosis.. [DOI: 10.1101/2022.09.01.506096] [Reference Citation Analysis]
11 Zhuo W, Wen Y, Luo H, Luo Z, Wang L. Mechanisms of ferroptosis in chronic kidney disease. Front Mol Biosci 2022;9:975582. [DOI: 10.3389/fmolb.2022.975582] [Reference Citation Analysis]
12 Zhang Y, Cai J, Lu W, Xu S, Qu M, Zhao S, Ding X. Comprehensive Network-Based Analyses Reveal Novel Renal Function-Related Targets in Acute Kidney Injury. Front Genet 2022;13:907145. [DOI: 10.3389/fgene.2022.907145] [Reference Citation Analysis]
13 Sandholm N, Cole JB, Nair V, Sheng X, Liu H, Ahlqvist E, van Zuydam N, Dahlström EH, Fermin D, Smyth LJ, Salem RM, Forsblom C, Valo E, Harjutsalo V, Brennan EP, McKay GJ, Andrews D, Doyle R, Looker HC, Nelson RG, Palmer C, McKnight AJ, Godson C, Maxwell AP, Groop L, McCarthy MI, Kretzler M, Susztak K, Hirschhorn JN, Florez JC, Groop PH; GENIE Consortium. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease. Diabetologia 2022. [PMID: 35763030 DOI: 10.1007/s00125-022-05735-0] [Reference Citation Analysis]
14 Hill C, Avila-palencia I, Maxwell AP, Hunter RF, Mcknight AJ. Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.923068] [Reference Citation Analysis]
15 Doke T, Susztak K. The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol 2022:S0962-8924(22)00084-8. [PMID: 35473814 DOI: 10.1016/j.tcb.2022.03.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ide K, Souma T. In Vivo Assessment of Ferroptosis and Ferroptotic Stress in Mice. Curr Protoc 2022;2:e413. [PMID: 35384401 DOI: 10.1002/cpz1.413] [Reference Citation Analysis]
17 Sakashita M, Nangaku M. Multi-omics studies reveal genes critical for AKI and ferroptosis. Kidney International 2022;101:665-7. [DOI: 10.1016/j.kint.2021.10.032] [Reference Citation Analysis]
18 von Mässenhausen A, Zamora Gonzalez N, Maremonti F, Belavgeni A, Tonnus W, Meyer C, Beer K, Hannani MT, Lau A, Peitzsch M, Hoppenz P, Locke S, Chavakis T, Kramann R, Muruve DA, Hugo C, Bornstein SR, Linkermann A. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci Adv 2022;8:eabl8920. [PMID: 35108055 DOI: 10.1126/sciadv.abl8920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
19 Lau A, Rahn JJ, Chappellaz M, Chung H, Benediktsson H, Bihan D, von Mässenhausen A, Linkermann A, Jenne CN, Robbins SM, Senger DL, Lewis IA, Chun J, Muruve DA. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury. Sci Adv 2022;8:eabm0142. [PMID: 35108057 DOI: 10.1126/sciadv.abm0142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Maremonti F, Meyer C, Linkermann A. Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss. J Am Soc Nephrol 2022:ASN. [PMID: 35022311 DOI: 10.1681/ASN.2021101293] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
21 Vastrad B, Vastrad C. Bioinformatics analysis of differentially expressed genes in non alcoholic fatty liver disease using next generation sequencing data.. [DOI: 10.1101/2021.12.16.472893] [Reference Citation Analysis]
22 Kondratyev NV, Alfimova MV, Golov AK, Golimbet VE. Bench Research Informed by GWAS Results. Cells 2021;10:3184. [PMID: 34831407 DOI: 10.3390/cells10113184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Allison SJ. DPEP1 and CHMP1A in kidney ferroptosis. Nat Rev Nephrol 2021;17:707. [PMID: 34561671 DOI: 10.1038/s41581-021-00496-2] [Reference Citation Analysis]
24 Sandholm N, Cole JB, Nair V, Sheng X, Liu H, Ahlqvist E, van Zuydam N, Dahlström EH, Fermin D, Smyth LJ, Salem RM, Forsblom C, Valo E, Harjutsalo V, Brennan EP, Mckay G, Andrews D, Doyle R, Looker HC, Nelson RG, Palmer C, Mcknight AJ, Godson C, Maxwell AP, Groop L, Mccarthy MI, Kretzler M, Susztak K, Hirschhorn JN, Florez JC, Groop P, for the GENIE Consortium. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.. [DOI: 10.1101/2021.08.27.21262264] [Reference Citation Analysis]